Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | ARS: Annual Report to Security Holders
Anavex Life Sciences | DEFA14A: Others
Anavex Life Sciences | DEF 14A: Definitive information statements
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Donhauser Peter D.O.
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Ma Jiong
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Skarpelos Athanasios
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Thomas Steffen
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Velden Claus Vander
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 10-Q: Q1 2025 Earnings Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 10-K: FY2024 Annual Report
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer MISSLING CHRISTOPHER U
Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Boenisch Sandra
Anavex Life Sciences | 10-Q: Q3 2024 Earnings Report